| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 04/17/2003 | WO2003000271A3 System and method for the large scale labeling of compounds with radiohalogens |
| 04/17/2003 | US20030073640 Novel compositions for the delivery of negatively charged molecules |
| 04/17/2003 | US20030073112 Amplificaton of nucleotide sequences present in sample; provide sample containing nucleotide sequnces, incubate with primers, amplify sequences, detect amplified product |
| 04/17/2003 | US20030072712 For use as labels in diagnostic assays and in enhancing binding to complementary bases |
| 04/16/2003 | WO2003016423A1 Hydrogelation agents |
| 04/16/2003 | EP1302474A1 Monocyclic L-nucleosides, analogs and uses thereof |
| 04/16/2003 | EP1301523A1 N8 - and c8 -linked purine bases and structurally related heterocycles as universal nucleosides used for oligonucleotide hybridization |
| 04/16/2003 | EP1301519A2 Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same |
| 04/16/2003 | EP1261350A4 METHODS FOR SYNTHESIZING 2-CHLORO-9-(2-DEOXY-2-FLUORO-$g(b)-D-ARABINOFURANOSYL)- i 9H /i -PURIN-6-AMINE |
| 04/16/2003 | EP0931038B1 Novel substance library and supramolecular complexes produced therewith |
| 04/15/2003 | US6548486 New viricide compounds of the general formula: Nu-O-Fa, wherein O represents an oxygen, Nu is a nucleoside or nucleoside analogue, and Fa is an acyl group of mono-unsaturated c18-c20 fatty acid |
| 04/15/2003 | CA2190007C Antitumor indolopyrrolocarbazole derivatives |
| 04/10/2003 | WO2003029265A1 Inosinie/l-arginine salt and use thereof |
| 04/10/2003 | WO2003029264A2 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof |
| 04/10/2003 | WO2003028748A1 A method of extracting deoxyadenosins components from cordyceps sinensis |
| 04/10/2003 | WO2002072791A3 Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid support |
| 04/10/2003 | US20030069414 Compound for use in the diagnosis and treatment of viral, bacterial and cancer diseases |
| 04/10/2003 | US20030069256 Use of isogenic human cancer cells for high-throughput screening and drug discovery |
| 04/10/2003 | US20030069204 Strain of streptomyces |
| 04/10/2003 | US20030069168 Especially flavanoids or chromones containing a rhamnose group that have selective inhibitory activity against the activated T cells |
| 04/10/2003 | US20030068633 Preparation of expression vector; prepare microarray on substrate, incubate with pool of single stranded nucleotide sequences, detect bound sequences, release sequences from microarray, allow sequences to aggregate, recover sequences |
| 04/10/2003 | US20030068301 Nucleic acid molecules, including antisense and enzymatic nucleic acid molecules which modulate synthesis, expression and/or stability of an RNA encoding one or more protein components of Hepatitis B virus |
| 04/09/2003 | EP1021457B1 Method for the site specific synthesis of novel 3-hydroxypyridin-4(1h)-ones derivatives from aminoitols, products obtained by this method and their applications |
| 04/09/2003 | EP1003758B1 Solution phase synthesis of oligonucleotides |
| 04/09/2003 | EP0808320B1 Novel chain terminators, the use thereof for nucleic acid sequencing and synthesis and a method of their preparation |
| 04/09/2003 | CN1409721A Treatment of viral infections using LEVOVIRIN |
| 04/09/2003 | CN1408720A Process for producing adenosin by chemical synthesis |
| 04/09/2003 | CN1408719A Process for separating nucleotide from ribonucleic acid enzymolysis liquid using cationic exchanging resin |
| 04/09/2003 | CN1408257A Separating and extracting method for date cyclic nucleotide syrup, dietary fibre and date wax |
| 04/08/2003 | US6545134 Method for the production of pentopyranosyl nucleosides |
| 04/08/2003 | US6545001 Antiviral nucleoside analogues |
| 04/08/2003 | US6544960 Chemical compounds |
| 04/08/2003 | US6544959 High affinity nucleic acid ligands to lectins |
| 04/08/2003 | US6544739 Method for marking samples |
| 04/03/2003 | WO2003027632A2 Use of isogenic human cancer cells for high-throughput screening and drug discovery |
| 04/03/2003 | WO2003027314A2 Protected linker compounds |
| 04/03/2003 | WO2003027060A1 Diphenylbutane amide derivatives |
| 04/03/2003 | WO2003026675A1 Methods and compositions for treating flaviviruses and pestiviruses using 4'-modified nucleoside |
| 04/03/2003 | WO2003026589A2 Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides |
| 04/03/2003 | WO2002100152A3 Solution-phase combinatiorial library synthesis and pharmaceutically active compounds produced thereby |
| 04/03/2003 | US20030065023 Anticancer agents, viricides, psychological disorders |
| 04/03/2003 | US20030064943 High affinity TGFbeta nucleic acid ligands and inhibitors |
| 04/03/2003 | US20030064492 Nucleotide sequences for use as tool in human therapeutics and diagnostics |
| 04/03/2003 | US20030064391 Preparation of sequences on substrate; obtain substrate, deposit on plate surface, incubate with activator, remove protective groups, recover biopolymer |
| 04/03/2003 | US20030064364 Nucleic acid analysis techniques |
| 04/03/2003 | CA2461532A1 Use of isogenic human cancer cells for high-throughput screening and drug discovery |
| 04/02/2003 | EP1296997A1 Base analogues |
| 04/02/2003 | EP1296996A1 Purine derivatives |
| 04/02/2003 | EP1296995A2 3'-prodrugs of 2'-deoxy-beta-l-nucleosides |
| 04/02/2003 | EP1296713A1 Immunostimulatory oligodeoxynucleotides |
| 04/02/2003 | EP1296690A2 METHOD FOR THE TREATMENT OR PREVENTION OF i FLAVIVIRUS /i INFECTIONS USING NUCLEOSIDE ANALOGUES |
| 04/02/2003 | EP1019887B1 Fluorescent cyanine dyes |
| 04/02/2003 | EP0998482B1 Process for the preparation of 2'-fluoro-5-methyl-beta-l-arabinofuranosyluridine |
| 04/02/2003 | EP0986570B1 Gemcitabine derivatives |
| 04/02/2003 | EP0763049B1 Nucleoside monophosphate derivatives, a process for their production and their use as immunosuppressive drugs |
| 04/02/2003 | EP0621865B1 Rapamycin derivative and its medicinal use |
| 04/02/2003 | CN1406946A Technology for producing AR with IR as initiation material by liquid ammonia process |
| 04/02/2003 | CN1104438C 槲寄生提取物及其用途 Mistletoe extract and use |
| 04/01/2003 | US6541626 Protecting/blocking the exocyclic amino function of purine nucleosides without effecting hydroxyl groups of sugar moieties via forming activated ester |
| 04/01/2003 | US6541618 Nitro-substituted non-fluorescent asymmetric cyanine dye compounds |
| 03/27/2003 | WO2003024980A1 Preparation of triphosphosrylated organic compounds optionally marked with phosphorus 32 or phosphorus 33 |
| 03/27/2003 | WO2002044195A3 Method for base sequencing and biologically active nucleic acids |
| 03/27/2003 | US20030060622 Preparation of a 2'-deoxy-2'-halo- beta -L- arabinofuranosyl nucleoside; obtain 2-deoxy-2-halo-L- arabinopyranose, convert to 2-deoxy-2-halo-L-arabinofuranose |
| 03/27/2003 | US20030060621 Preparation of indolopyrrolocarbazole derivative; obtain chemical intermediates, deblock and recover indolopyrrolocarbazole derivative |
| 03/27/2003 | US20030060431 Base analogues |
| 03/27/2003 | US20030060400 A modified nucleoside comprising a purine or pyrimidine ring for treating viral infections |
| 03/27/2003 | US20030059785 Detection of markers in nascent proteins |
| 03/27/2003 | US20030059769 High affinity nucleic acid ligands to lectins |
| 03/26/2003 | EP1295892A1 Antisense molecules and method of controlling expression of gene function by using the same |
| 03/26/2003 | EP1295891A1 Nucleoside derivatives |
| 03/26/2003 | EP1295890A1 Novel pyrazine derivatives or salts thereof, pharmaceutical composition containing the same, and production intermediates thereof |
| 03/26/2003 | EP1294735A2 Methods and compositions for treating flaviviruses and pestiviruses |
| 03/26/2003 | EP1294362A1 Novel process for preparing crystalline particles |
| 03/26/2003 | EP0969822B1 Determination of the propensity of an organ or tissue for cancer by determining of its imprinting pattern |
| 03/26/2003 | CN1406242A Process for the preparation of phosphorothioate triesters |
| 03/26/2003 | CN1405173A Sulfated zidovudine (1-4) polysaccharidase preparation method |
| 03/26/2003 | CN1103593C Synergistic composition |
| 03/25/2003 | WO2003000254A1 Fused cyclic compounds and medicinal use thereof |
| 03/25/2003 | US6537975 Aryl phosphate derivatives of d4T with para-bromo substitution on the aryl group show markedly increased potency as anti-HIV agents without undesirable levels of cytotoxic activity. In particular, these derivatives are potent |
| 03/25/2003 | US6537974 Method of treating arrhythmias |
| 03/25/2003 | US6537783 Prefunctionalized nucleotide and process for amplifying a sequence using a prefunctionalized nucleotide |
| 03/25/2003 | CA2423800A1 Fused cyclic compounds and medicinal use thereof |
| 03/25/2003 | CA2051239C Prodrugs of phosphonates |
| 03/20/2003 | WO2003022861A1 Process for the preparation of rebeccamycin and analogs thereof |
| 03/20/2003 | WO2003022859A2 Process for the synthesis of pyrazolopyrimidines |
| 03/20/2003 | WO2003022290A1 Medicinal compositions for diabetic neuropathy |
| 03/20/2003 | WO2003002104A3 Use of corrinoids in the treatment of skin diseases |
| 03/20/2003 | WO2002074910A3 Selective anti-viral nucleoside chain terminators |
| 03/20/2003 | WO2002067951A3 Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases |
| 03/20/2003 | WO2001087913A9 Method for treating retinal degeneration with purinergic receptor agonists |
| 03/20/2003 | US20030055257 Water-soluble rhodamine dye conjugates |
| 03/20/2003 | US20030055243 Atropisomers of asymmetric xanthene fluorescent dyes and methods of DNA sequencing and fragment analysis |
| 03/20/2003 | US20030055235 Genetically engineered transferase for use as tool in genetic engineering |
| 03/20/2003 | US20030055021 Compounds for the treatment of ischemia |
| 03/20/2003 | US20030055016 Useful in structural determinations, particularly by X-ray crystallographic techniques; useful as food supplements |
| 03/20/2003 | US20030054983 Antibiotics AA-896 |
| 03/20/2003 | US20030054512 Autoinducer synthase modulating compounds and uses therefore |
| 03/20/2003 | US20030054508 Substantially pure glycopeptide antibotics AC-98-1; AC-98-2; AC-98-3; AC-98-4 AND AC-98-5 |
| 03/20/2003 | US20030054439 Truncated soluble tumor necrosis factor type-I and type-II receptors |
| 03/20/2003 | US20030054410 Combinatorial protecting group strategy for multifunctional molecules |